» Articles » PMID: 31248877

ETV6-related Thrombocytopenia and Leukemia Predisposition

Overview
Journal Blood
Publisher Elsevier
Specialty Hematology
Date 2019 Jun 29
PMID 31248877
Citations 27
Authors
Affiliations
Soon will be listed here.
Abstract

Germ line mutations in are responsible for a familial thrombocytopenia and leukemia predisposition syndrome. Thrombocytopenia is almost completely penetrant and is usually mild. Leukemia is reported in ∼30% of carriers and is most often B-cell acute lymphoblastic leukemia. The mechanisms by which ETV6 dysfunction promotes thrombocytopenia and leukemia remain unclear. Care for individuals with ETV6-related thrombocytopenia and leukemia predisposition includes genetic counseling, treatment or prevention of excessive bleeding and surveillance for the development of hematologic malignancy.

Citing Articles

Genetic predisposition to myelodysplastic syndrome: Genetic counseling and transplant implications.

Liu Y, Calzone K, McReynolds L Semin Hematol. 2024; 61(6):370-378.

PMID: 39443230 PMC: 11661499. DOI: 10.1053/j.seminhematol.2024.09.003.


The Diverse Roles of ETV6 Alterations in B-Lymphoblastic Leukemia and Other Hematopoietic Cancers.

Monovich A, Gurumurthy A, Ryan R Adv Exp Med Biol. 2024; 1459:291-320.

PMID: 39017849 DOI: 10.1007/978-3-031-62731-6_13.


Germ line ERG haploinsufficiency defines a new syndrome with cytopenia and hematological malignancy predisposition.

Zerella J, Homan C, Arts P, Lin X, Spinelli S, Venugopal P Blood. 2024; 144(17):1765-1780.

PMID: 38991192 PMC: 11530364. DOI: 10.1182/blood.2024024607.


Insights into the Molecular Mechanisms of Genetic Predisposition to Hematopoietic Malignancies: The Importance of Gene-Environment Interactions.

Cobaleda C, Godley L, Nichols K, Wlodarski M, Sanchez-Garcia I Cancer Discov. 2024; 14(3):396-405.

PMID: 38426560 PMC: 10913756. DOI: 10.1158/2159-8290.CD-23-1091.


Germline Variants and Characteristic Features of Hereditary Hematological Malignancy Syndrome.

Arai H, Matsui H, Chi S, Utsu Y, Masuda S, Aotsuka N Int J Mol Sci. 2024; 25(1).

PMID: 38203823 PMC: 10779750. DOI: 10.3390/ijms25010652.


References
1.
Fenrick R, Wang L, Nip J, Amann J, Rooney R, Walker-Daniels J . TEL, a putative tumor suppressor, modulates cell growth and cell morphology of ras-transformed cells while repressing the transcription of stromelysin-1. Mol Cell Biol. 2000; 20(16):5828-39. PMC: 86060. DOI: 10.1128/MCB.20.16.5828-5839.2000. View

2.
Noetzli L, Lo R, Lee-Sherick A, Callaghan M, Noris P, Savoia A . Germline mutations in ETV6 are associated with thrombocytopenia, red cell macrocytosis and predisposition to lymphoblastic leukemia. Nat Genet. 2015; 47(5):535-538. PMC: 4631613. DOI: 10.1038/ng.3253. View

3.
Rampersaud E, Ziegler D, Iacobucci I, Payne-Turner D, Churchman M, Schrader K . Germline deletion of in familial acute lymphoblastic leukemia. Blood Adv. 2019; 3(7):1039-1046. PMC: 6457220. DOI: 10.1182/bloodadvances.2018030635. View

4.
Wang M, Gu D, Du M, Xu Z, Zhang S, Zhu L . Common genetic variation in ETV6 is associated with colorectal cancer susceptibility. Nat Commun. 2016; 7:11478. PMC: 4858728. DOI: 10.1038/ncomms11478. View

5.
Gunji H, Waga K, Nakamura F, Maki K, Sasaki K, Nakamura Y . TEL/AML1 shows dominant-negative effects over TEL as well as AML1. Biochem Biophys Res Commun. 2004; 322(2):623-30. DOI: 10.1016/j.bbrc.2004.07.169. View